Skip to main content Skip to footer

Ronan J Kelly, MD, MBA, Chief of Oncology

Medical Oncology
About

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018.

Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals.

Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas.

Publications

 



LanguagesEnglish
Ages SeenAdults, Geriatrics
Hospital Affiliations
  • Baylor University Medical Center, part of Baylor Scott & White Health
Insurance Accepted
*Accepted plans and benefits may vary by location.
INSURANCE PLAN
ACCEPTS NEW PATIENTS
Scott & White Health Plan - BSW Preferred EPO Network
Scott & White Health Plan - BSW Preferred HMO - Large Group
Scott & White Health Plan - BSW Preferred HMO Network
Scott & White Health Plan - BSW Preferred PPO Network
Scott & White Health Plan - BSWH Employee Network - PPO & HSA
Scott & White Health Plan - EPO Network-Group
Scott & White Health Plan - EPO Network-Individual/Family
Scott & White Health Plan - ERS BSW Preferred HMO Network
Scott & White Health Plan - HMO Network - Large Group
Scott & White Health Plan - HMO Network-Group
Scott & White Health Plan - HMO Network-Individual/Family
Scott & White Health Plan - McLane Group Network
Scott & White Health Plan - PPO Network-Group
Scott & White Health Plan - SeniorCare Advantage HMO
Scott & White Health Plan - SeniorCare Advantage PPO
Scott & White Health Plan - TRS - Active Care Participants Network
Insurance listings are subject to change without prior notice. Please call the physician's office or health plan to verify coverage information prior to scheduling your visit or procedure. PPO Network Agreements include participating Employers and/or Administrator only. Not all members participating in contracted networks have in network access. Networks include Beech Street, HealthSmart, PHCS and Texas True Choice. In network participation is updated on a monthly basis by the network. Baylor Scott & White Health does not manage the insurances accepted for this doctor. Please contact the office directly to confirm coverage.
Background
Education
  • Medical School: The Royal College of Surgeons in Ireland (1998)
  • Residency: Internal Medicine, The Royal College of Physicians in Ireland (2002)
  • Fellowship: Medical Oncology, The Royal College of Physicians in Ireland (2007)
  • Fellowship: Medical Oncology, The National Cancer Institute, National Institutes of Health, Bethesda MD (2009)
  • Fellowship: Medical Oncology, Waterford Regional Hospital-Waterford Ireland (2005)
  • Fellowship: Medical Oncology, Beaumont Hospital-Dublin, Ireland (2006)
  • Fellowship: Medical Oncology, Adelaide & Mental Hospital-National Children's Hospital, Dublin (2007)
  • Fellowship: Medical Oncology, National Cancer Insititute-Bethesda (2009)
  • Residency: Internal Medicine, Beaumont Hospital-Dublin, Ireland (2000)
  • Residency: Medical , Mater Misericordiae Hospital-Dublin, Ireland (2004)
  • Medical School: National University Of Ireland. The Royal College Of Surgeons In Ireland (1998)
Certifications
  • Internal Medicine - American Board of Internal Medicine
Industry Relationships

Baylor Scott & White Health’s vision is to be the most trusted name in giving and receiving safe, quality, compassionate healthcare.As part of that vision, Baylor Scott &White Health is committed to dealing honestly, fairly and with integrity in all matters to provide exemplary patient care, broaden medical knowledge, train the next generation of physicians and support outside relationships that promise public benefit.To that end, Baylor Scott & White Health physicians may collaborate with health care industry partners such as pharmaceutical, biotech, or medical device companies(collectively referred to as Industry) to help develop medical breakthroughs, or provide medical expertise or education.To promote professional and commercial integrity in such matters, physicians who are employed, contracted for administrative duties or performing research with Baylor Scott & White Health seek advanced approval for certain new Industry relationships, and report their Industry relationships and activities to the Office of Corporate Compliance annually for review.

Baylor Scott & White Health publicly discloses reported payments to these physicians and their immediate family members of $5,000 or more from Industry companies with which the physicians interact as part of their professional activities.The information on this website may differ somewhat from information on other publicly available databases due to different reporting periods, definitions, or reporting requirements.Patients may visit CMS’ Open Payments Database for more information, and should feel free to speak with their physician about relationships with Industry.

As of Mar 4, 2019, Ronan J Kelly, MD, MBA, Chief of Oncology disclosed the following outside relationships with Industry:

VendorDescription
Cardinal Health 108, LLC
Reviews
No reviews have been submitted for this doctor.
Scroll To Top